ETOVEL
Description
Etoposide is a chemotherapeutic drug that has stood the test of time. It is used extensively in chemotherapy regimens for small cell lung cancer (SCLC), germ cell tumours, neuroblastoma and haematological malignancies like acute leukemias and lymphomas.
Indications:
- Erlotinib is prescribed as initial treatment for patients with NSCLC whose cancer has spread to other parts of the body and that has certain types of epidermal growth factor receptor (EGFR) mutations. (1st-line treatment)
- Prescribed as 2nd- or 3rd-line treatment for advanced-stage NSCLC in patients whose cancer has spread or grown after receiving at least one round of chemotherapy.
- Erlotinib in combination with gemcitabine is prescribed for patients with advanced-stage pancreatic cancer whose cancer has spread, grown, or cannot be surgically removed and who have not received previous chemotherapy.
| Generic Name | Strength | Standard | Type | Packing | Pack Size |
| Erlotinib | 150 mg | IP | Tablet | Bottle | 1 X 10 |
| Erlotinib | 100 mg | IP | Tablet | Bottle | 1 X 10 |